AI Execution Risks Threaten Aquestive Therapeutics' Competitiveness and Profitability
The company also confronts execution risk , as intense competition for AI talent, data readiness challenges, and the possibility of underperforming AI ...
Read the original at The Globe and Mail ↗
- Tracked via
- “AI Risks”